The 5 Most Interesting Analyst Questions From Merck’s Q1 Earnings Call - Yahoo Finance
  Amarin, Merck alum Karim Mikhail emerges as possible head of FDA’s CDER - biocentury.com
  Exclusive: Kennedy's new vaccine adviser was expert witness against Merck vaccine - Reuters
  FDA approves Merck’s RSV shot for infants, ramping up competition with Sanofi and AstraZeneca - CNBC
  Merck held talks to buy Swiss biotech MoonLake for more than $3bn - Financial Times
  Merck's potential blockbuster cholesterol pill succeeds in late-stage studies - Reuters
  Targeted cancer drugs may replace chemo for some patients — and drugmakers say they're getting closer - CNBC
  As Trump proposes NIH cuts, a top Merck executive sees fragility in a 'super-highway for biomedicine' - STAT